✦ LIBER ✦

Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group

✍ Scribed by K. Baumann; J. Pfisterer; P. Wimberger; N. Burchardi; C. Kurzeder; A. du Bois; S. Loibl; J. Sehouli; J. Huober; B. Schmalfeldt; I. Vergote; H.J. Lück; U. Wagner

Book ID: 113963276
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 255 KB
Volume: 123
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

42 Phase I study for treatment of ovaria

42 Phase I study for treatment of ovarian cancer patients with symptomatic ascites using the trifunctional bispecific antibody removab® (anti-CD3 X anti-EpCAM)

✍ A. Burges; P. Wimberger; V.A. Gorbounova; H. Sommer; B. Schmalfeldt; J. Pfistere 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Gefitinib in combination with tamoxifen

Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum–taxane based therapy—A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)

✍ Uwe Wagner; Andreas du Bois; Jacobus Pfisterer; Jens Huober; Sybille Loibl; Hans 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A multicenter phase II study of the cryp

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer

✍ G D’AGOSTINO; J DEL CAMPO; B MELLADO; M.A. IZQUIERDO; T MINARIK; L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

A Phase I Study of Intraperitoneal Inter

A Phase I Study of Intraperitoneal Interferon-α2band Intravenouscis-Platinum plus Cyclophosphamide Chemotherapy in Patients with Untreated Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Pilot Study

✍ DAVID H. MOORE; FIDEL VALEA; LESLIE A. WALTON; JOHN SOPER; DANIEL CLARKE-PEARSON 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 78 KB

39 Topotecan versus treosulfan in recurr

39 Topotecan versus treosulfan in recurrent ovarian cancer after initial chemotherapy with platinum and paclitaxel. a prospective randomised phase III study of the AGO ovarian cancer study group

✍ S. Loibl; W. Meier; A. du Bois; W. Kuhn; J. Pfisterer; R. Kimmig; S. Olbricht; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase II, single-arm study of the anti

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

✍ Katherine M. Bell-McGuinn; Carolyn M. Matthews; Steffan N. Ho; Minal Barve; Lucy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 586 KB